Delayed hypersensitivity response to oxazolone in neonatally estrogenized mice

Area of Science:

• Immunology
• Endocrinology
• Developmental Toxicology

Background:

• Diethylstilbestrol (DES) is a synthetic estrogen with known endocrine-disrupting properties.
• Neonatal exposure to endocrine disruptors can have long-lasting effects on immune system development and function.

Purpose of the Study:

• To investigate the long-term effects of neonatal diethylstilbestrol (DES) exposure on the immune system in mice.
• To assess the impact of DES on the delayed hypersensitivity reaction, a key component of cell-mediated immunity.

Main Methods:

• Neonatal NMRI mice were exposed to diethylstilbestrol (DES) during the first 5 days of life.
• Delayed hypersensitivity reactions were evaluated at 6 and 9 months of age using an oxazolone ear challenge test.
• Immune responses in DES-treated mice were compared to age-matched control groups.

Main Results:

• Diethylstilbestrol (DES)-treated mice exhibited a significantly diminished delayed hypersensitivity response to oxazolone compared to control mice.
• This immunosuppressive effect was observed at both 6 and 9 months of age, indicating a persistent impact.
• The findings suggest that early-life exposure to DES alters immune system maturation and function.

Conclusions:

• Neonatal exposure to diethylstilbestrol (DES) can lead to long-term impairment of cell-mediated immunity in mice.
• The study highlights the critical window of vulnerability during early development for endocrine disruptor effects on the immune system.
• These findings have implications for understanding the potential immunotoxicity of environmental estrogens.